Evaluation of polycystic ovary syndrome pharmacotherapy.

Kolesárová M, Zálešová N, Marcinčáková D, Dalibor K, Mačeková Z

Open source

DOI
10.36290/csf.2024.031
Published
2024
Container
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36290/csf.2024.031,
  title = {Evaluation of polycystic ovary syndrome pharmacotherapy.},
  author = {Kolesárová M and Zálešová N and Marcinčáková D and Dalibor K and Mačeková Z},
  year = {2024},
  journal = {Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti},
  doi = {10.36290/csf.2024.031},
  url = {https://doi.org/10.36290/csf.2024.031}
}

RIS

TY  - JOUR
TI  - Evaluation of polycystic ovary syndrome pharmacotherapy.
AU  - Kolesárová M
AU  - Zálešová N
AU  - Marcinčáková D
AU  - Dalibor K
AU  - Mačeková Z
PY  - 2024
JO  - Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
DO  - 10.36290/csf.2024.031
UR  - https://doi.org/10.36290/csf.2024.031
ER  - 

APA

M, K., N, Z., D, M., K, D., & Z, M. (2024). Evaluation of polycystic ovary syndrome pharmacotherapy.. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. https://doi.org/10.36290/csf.2024.031

Source records